Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study
By A. Ruitenberg, T. den Heijer, S. Bakker, J. V. van Swieten, P. Koudstaal, Albert Hofman, Monique M. B. Breteler. Annals of Neurology, 2005
786 citations recorded by the source corpus.
Subfields: Neurology, Psychiatry and Mental health, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/0f3a098080e888fafb7434554fa70edd0ec90b6f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
- C. Iadecola
- Berislav Zlokovic
- R. Bell
- David H. Salat
- J. Jean Chen
- H. Rosas
- A. Rodriguez-Mateos
- A. Crozier
In Psychiatry and Mental health
In Pulmonary and Respiratory Medicine
- A. Rodriguez-Mateos
- H. Rosas
- A. Crozier
- J. Spencer
- Massimiliano Tognolini
- Berislav Zlokovic
- David H. Salat
- G. Borges
Citations in the corpus
- The blood-brain barrier in health and chronic neurodegenerative disorders. (2008, positive): “Vascular Factors Vascular risk factors might be responsible for cognitive decline in the elderly according to several epidemiologic studies, including the largest population-based Rotterdam study (Hofman et al., 1997; Ruitenberg et al., 2005).”
- Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention (2009, background): “However, studies with a longer follow-up period follow-up (eg, >6 years) have also reported an inverse association,(77-79) suggesting that low blood pressure in late life may contribute to the development or clinical expression of dementia and AD.(74,80) Longitudinal studies repeatedly show a protec”
- Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases (2013, positive): “The ability of flavonoids to exert peripheral vascular changes (30, 66, 78, 83, 86, 97, 98, 147, 226) may facilitate more efficient cerebral blood flow (CBF), something that is known to deteriorate with age, to be vital for optimal brain function, and to be decreased in patients with dementia (163, ”
- Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders (2011, background): “Reduced CBF and/or CBF dysregulation occurs in elderly individuals at high risk of Alzheimer's disease before cognitive decline, brain atrophy and amyloid-β accumulatio”
- Age-Associated Reductions in Cerebral Blood Flow Are Independent from Regional Atrophy (2010, background): “…Dai et al., 2008c, 2009; Uh et al., 2010) suggest vascular contributions to Alzheimer's disease (AD) and other dementia (Bell and Zlokovic, 2009; Caroli et al., 2007; de la Torre, 2005; Dickstein et al., 2010; Helzner et al., 2009; Ruitenberg et al., 2005; Sachdev et al., 1999; Zlokovic, 2005).”
- Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease (2009, background): “Longitudinal data from a large population-based study (1,730 participants of the Rotterdam Study), showed that higher CBF velocity, measured by transcranial doppler flowmetry, was related to a lower prevalence of cognitive decline [72].”
- The pathobiology of vascular dementia (2013, positive): “…in patients with early AD or at risk for AD (Claassen et al., 2009; Gao et al., 2013; Luckhaus et al., 2008; Mentis et al., 1996; Niedermeyer, 2006; Ruitenberg et al., 2005; Sabayan et al., 2012; Tanaka et al., 2002), implicating reduced cerebral perfusion in the pathobiology of the disease…”